n(g)-iminoethylornithine has been researched along with epidermal growth factor in 1 studies
| Studies (n(g)-iminoethylornithine) | Trials (n(g)-iminoethylornithine) | Recent Studies (post-2010) (n(g)-iminoethylornithine) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 171 | 1 | 36 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clementi, E; Nisticò, G; Sciorati, C | 1 |
1 other study(ies) available for n(g)-iminoethylornithine and epidermal growth factor
| Article | Year |
|---|---|
Growth factor-induced Ca2+ responses are differentially modulated by nitric oxide via activation of a cyclic GMP-dependent pathway.
Topics: 3T3 Cells; Animals; Calcium; Calcium Channels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Epidermal Growth Factor; Homeostasis; Humans; Manganese; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Ornithine; Platelet-Derived Growth Factor; Receptors, Growth Factor; Second Messenger Systems; Signal Transduction; Stimulation, Chemical; Terpenes; Thapsigargin | 1995 |